SEC Form 4 · accession 0001179110-15-000774
ACCELERON PHARMA INC · XLRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven D Ertel
Officer — SVP & Chief Business Officer
Period of report
Jan 8, 2015
Accepted (ET)
Jan 9, 2015 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001280600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $41.20 | Jan 8, 2015 | A | 41,000 | A | — | Jan 8, 2025 | Common Stock | 41,000 | 41,000 | D |
Explanation of responses
- F1The shares of common stock underlying this stock option award vest in equal quarterly installments over the first four years after the grant.